Oncogenic SRSF3 in health and diseases

R Jia, ZM Zheng - International Journal of Biological Sciences, 2023 - pmc.ncbi.nlm.nih.gov
Serine/arginine rich splicing factor 3 (SRSF3) is an important multi-functional splicing factor,
and has attracted increasing attentions in the past thirty years. The importance of SRSF3 is …

Loss of HIF1A from pancreatic cancer cells increases expression of PPP1R1B and degradation of p53 to promote invasion and metastasis

A Tiwari, K Tashiro, A Dixit, A Soni, K Vogel, B Hall… - Gastroenterology, 2020 - Elsevier
Background & Aims Pancreatic ductal adenocarcinomas (PDACs) are hypovascular,
resulting in the up-regulation of hypoxia inducible factor 1 alpha (HIF1A), which promotes …

DARPP-32 40 years later

JA Girault, AC Nairn - Advances in Pharmacology, 2021 - Elsevier
Abstract DARPP-32 (dopamine-and cAMP-regulated phosphoprotein with an apparent Mr of
32,000), now also known as phosphoprotein phosphatase 1 regulatory subunit 1B …

Urinary exosomal mRNA detection using novel isothermal gene amplification method based on three-way junction

J Moon, J Lim, S Lee, HY Son, HW Rho, H Kim… - Biosensors and …, 2020 - Elsevier
Exosomal messenger RNA (mRNA) has emerged as a valuable biomarker for liquid biopsy-
based disease diagnosis and prognosis due to its stability in body fluids and its biological …

ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation

SK Alam, L Wang, Y Ren, CE Hernandez… - British journal of …, 2020 - nature.com
Background Small cell lung cancer (SCLC) is the most aggressive form of lung cancer, and
new molecular insights are necessary for prognostic and therapeutic advances. Methods …

Controlling Ser/Thr protein phosphatase PP1 activity and function through interaction with regulatory subunits

A Casamayor, J Ariño - Advances in Protein Chemistry and Structural …, 2020 - Elsevier
Protein phosphatase 1 is a major Ser/Thr protein phosphatase activity in eukaryotic cells. It
is composed of a catalytic polypeptide (PP1C), with little substrate specificity, that interacts …

DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinoma

SK Alam, Y Zhang, L Wang, Z Zhu, CE Hernandez… - Oncogene, 2022 - nature.com
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-refractory lung
adenocarcinoma (LUAD) progression is a major clinical problem. New approaches to …

[HTML][HTML] Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice

F Yokoi, J Oleas, H **ng, Y Liu, KM Dexter… - Neurobiology of …, 2020 - Elsevier
DYT1 early-onset generalized torsion dystonia is a hereditary movement disorder
characterized by abnormal postures and repeated movements. It is caused mainly by a …

PP1, PKA and DARPP‐32 in breast cancer: A retrospective assessment of protein and mRNA expression

B Saidy, S Kotecha, A Butler, EA Rakha… - Journal of cellular …, 2021 - Wiley Online Library
Cyclic AMP–dependent protein kinase A (PKA) and protein phosphatase 1 (PP1) are
proteins involved in numerous essential signalling pathways that modulate physiological …

IKKα promotes lung adenocarcinoma growth through ERK signaling activation via DARPP-32-mediated inhibition of PP1 activity

SK Alam, L Wang, Z Zhu, LH Hoeppner - npj Precision Oncology, 2023 - nature.com
Non-small cell lung cancer (NSCLC) accounts for 80–85% cases of lung cancer cases.
Diagnosis at advanced stages is common, after which therapy-refractory disease …